Royal Bank of Canada
ONC

Royal Bank of Canada’s BeOne Medicines Ltd ONC Stock Holding History

Royal Bank of Canada’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.9M Buy
70,391
+2,399
+4% +$777K ﹤0.01% 1420
2025
Q4 		$20.7M Sell
67,992
-2,516
-4% -$824K ﹤0.01% 1482
2025
Q3 		$24M Buy
70,508
+3,037
+5% +$922K ﹤0.01% 1502
2025
Q2 		$16.3M Buy
67,471
+169
+0.3% +$41.4K ﹤0.01% 1682
2025
Q1 		$18.3M Sell
67,302
-2,188
-3% -$512K ﹤0.01% 1362
2024
Q4 		$12.8M Buy
69,490
+746
+1% +$152K ﹤0.01% 1646
2024
Q3 		$15.4M Sell
68,744
-24,183
-26% -$4.35M ﹤0.01% 1511
2024
Q2 		$13.3M Buy
92,927
+2,442
+3% +$376K ﹤0.01% 1502
2024
Q1 		$14.2M Buy
90,485
+34,233
+61% +$5.51M ﹤0.01% 1458
2023
Q4 		$10.1M Sell
56,252
-3,933
-7% -$712K ﹤0.01% 1714
2023
Q3 		$10.8M Sell
60,185
-3,001
-5% -$594K ﹤0.01% 1520
2023
Q2 		$11.3M Sell
63,186
-7,290
-10% -$1.68M ﹤0.01% 1502
2023
Q1 		$15.2M Buy
70,476
+446
+0.6% +$107K ﹤0.01% 1298
2022
Q4 		$15.4M Sell
70,030
-1,719
-2% -$315K ﹤0.01% 1321
2022
Q3 		$9.67M Sell
71,749
-4,813
-6% -$827K ﹤0.01% 1564
2022
Q2 		$12.4M Buy
76,562
+2,509
+3% +$392K ﹤0.01% 1424
2022
Q1 		$14M Buy
74,053
+24,020
+48% +$5.11M ﹤0.01% 1489
2021
Q4 		$13.6M Sell
50,033
-482
-1% -$163K ﹤0.01% 1677
2021
Q3 		$18.3M Buy
50,515
+3,575
+8% +$1.17M ﹤0.01% 1398
2021
Q2 		$16.1M Buy
46,940
+4,378
+10% +$1.45M ﹤0.01% 1500
2021
Q1 		$14.8M Buy
42,562
+18,086
+74% +$5.99M ﹤0.01% 1487
2020
Q4 		$6.32M Sell
24,476
-5,984
-20% -$1.65M ﹤0.01% 2026
2020
Q3 		$8.72M Buy
30,460
+11,520
+61% +$2.71M ﹤0.01% 1634
2020
Q2 		$3.57M Buy
18,940
+49
+0.3% +$7.98K ﹤0.01% 2179
2020
Q1 		$2.33M Buy
18,891
+189
+1% +$29.6K ﹤0.01% 2361
2019
Q4 		$3.1M Buy
18,702
+1,951
+12% +$324K ﹤0.01% 2503
2019
Q3 		$2.05M Buy
16,751
+1,070
+7% +$142K ﹤0.01% 2747
2019
Q2 		$1.94M Sell
15,681
-228
-1% -$28.9K ﹤0.01% 2799
2019
Q1 		$2.1M Sell
15,909
-28,479
-64% -$3.84M ﹤0.01% 2644
2018
Q4 		$6.22M Buy
44,388
+37,815
+575% +$5.01M ﹤0.01% 1822
2018
Q3 		$1.13M Buy
6,573
+6,367
+3,091% +$1.07M ﹤0.01% 3260
2018
Q2 		$32K Buy
+206
New +$36.7K ﹤0.01% 5348
2018
Q1 		– Sell
-96
Closed -$9K – 6869
2017
Q4 		$9K Sell
96
-111
-54% -$10.2K ﹤0.01% 5911
2017
Q3 		$21K Buy
207
+183
+763% +$13.6K ﹤0.01% 5933
2017
Q2 		$1K Buy
24
+20
+500% +$788 ﹤0.01% 6447
2017
Q1 		$0 Buy
+4
New +$146 ﹤0.01% 6859
2016
Q4 		– Sell
-9
Closed – – 6815
2016
Q3 		$0 Sell
9
-91
-91% -$2.64K ﹤0.01% 6611
2016
Q2 		$3K Buy
+100
New +$2.93K ﹤0.01% 6079

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada's ONC Position: Q1 2026 in Review

Royal Bank of Canada increased its BeOne Medicines Ltd (ONC) stake by 3.5% in Q1 2026, buying an estimated $777K and bringing the position to 70,391 shares worth $20.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Royal Bank of Canada first reported a position in ONC in Q2 2016 and has held it in 38 quarters since. The position peaked at $24M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Royal Bank of Canada held 70,391 shares of BeOne Medicines Ltd worth $20.9M as of Q1 2026.
  • Royal Bank of Canada bought 2,399 BeOne Medicines Ltd shares in Q1 2026, an estimated $777K.
  • BeOne Medicines Ltd made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1420 holding.
  • Royal Bank of Canada first reported a position in BeOne Medicines Ltd in Q2 2016 and has held it in 38 quarters since.
  • Royal Bank of Canada's BeOne Medicines Ltd position peaked at $24M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.